NOX4 and breast cancer: Nox4 activation by nodakenin treatment induced ROS and Ca2+ release, ER stress, and apoptotic cell death in breast cancer cell lines; however, Nox4 knockdown blocked ER stress and apoptotic cell death via ROS and Ca2+ release in nodakenin-treated breast cancer cell lines.